期刊文献+

结缔组织生长因子反义寡核苷酸对胰腺癌细胞基质金属蛋白酶-9、血管内皮生长因子表达及细胞增殖与侵袭的影响 被引量:3

Effect of CTGF antisense oligodeoxynucleotide on the expression of MMP-9,VEGF and proliferation,invasion in pancreatic cancer cells
原文传递
导出
摘要 目的通过研究结缔组织生长因子(CTGF)反义寡核苷酸(ASODN)对人胰腺癌细胞基质金属蛋白酶-9(MMP-9)、血管内皮生长因子(VEGF)表达及细胞增殖与侵袭力的影响,深入探讨CTGF在胰腺癌发生、发展中的作用机制,为CTGFASODN在胰腺癌基因治疗中的运用奠定理论基础。方法经脂质体介导将CTGFASODN转染人胰腺癌细胞株SW1990,荧光显微镜及流式细胞仪检测转染效率;逆转录-聚合酶链反应(RT-PCR)及Westernblot检测转染细胞CTGF、MMP-9与VEGFmRNA与蛋白表达;噻唑盐(MTT)比色法检测转染细胞的增殖活性;采用Transwell小室检测细胞侵袭能力。结果 (1)荧光显微镜及流式细胞仪检测显示CTGFASODN可成功转染SW1990细胞。(2)反义组、无义组和单加脂质体组细胞CTGFmRNA表达量分别为0.24±0.09、0.67±0.21、0.63±0.18,反义组较其他组的mRNA表达明显减少(P<0.01);相应的CTGF蛋白表达量分别为0.19±0.07、0.75±0.26、0.71±0.23;相应的MMP-9mRNA表达量分别为0.21±0.12、0.78±0.35、0.81±0.37;相应的VEGFmRNA表达量分别为0.16±0.06、0.42±0.22、0.43±0.28;相应的MMP-9蛋白表达量分别为0.68±0.22、1.97±0.46、1.92±0.39;相应的VEGF蛋白表达量分别为0.27±0.07、0.52±0.19、0.55±0.18,反义组CTGF、MMP-9和VEGF的表达较其他组显著降低(P<0.01)。(3)反义组、无义组、单加脂质体组细胞增殖活性分别为1.67±0.14、2.34±0.17、2.29±0.21,反义组较其他组细胞增殖被显著抑制(P<0.01)。(4)反义组、无义组、单加脂质体组微孔滤膜外侧细胞数分别为24.88±6.17、52.37±8.62、55.49±8.83,反义组较其他组微孔滤膜外侧细胞数显著减少(P<0.01)。结论 CTGFASODN转染可有效抑制SW1990细胞CTGF的表达,并降低其MMP-9、VEGF的表达及细胞增殖活性与细胞侵袭力。 Objective To investigate the effect of connective tissue growth factor antisense oligodeoxynucleotide(CTGF ASODN)on proliferation and invasion in human pancreatic cancer cell line SW1990,with a focus on the expression of matrix metalloproteinase-9(MMP-9)and vascular endothelial growth factor(VEGF).This study was designed to explore the underlying mechanism for the role of CTGF in the development of pancreatic cancer and the therapeutic value of gene therapy.Methods CTGF ASODN,nonsense oligodeoxynucleotide(NSODN)were transfected into SW1990 cells through lipofectamine.The transfection rate was accessed by fluorescence microscopy and flow cytometry.The expressions of CTGF,MMP-9 and VEGF in different groups of transfected cells were detected by RT-PCR and Western blot.Cell viability was assessed by MTT method.Results (1)Fluorescence microscopy and flow cytometry showed a successful transfection of CTGF ASODN in SW1990 cells.(2)The mRNA levels of CTGF,MMP-9 and VEGF in CTGF ASODN,NSODN and control groups were:CTGF 0.24±0.09,0.67±0.21,0.63±0.18;MMP-9 0.21±0.12,0.78±0.35,0.81±0.37;VEGF 0.16±0.06,0.42±0.22,0.43±0.28.Accordingly,protein levels were:CTGF 0.19±0.07,0.75±0.26,0.71±0.23;MMP-9 0.68±0.22,1.97±0.46,1.92±0.39;VEGF 0.27±0.07,0.52±0.19,0.55±0.18.The expressions of mRNA and protein of CTGF,MMP-9 and VEGF were significantly reduced in CTGF ASODN transfected group,compared with other two groups(P<0.01).(3)The A490 value of cells in CTGF ASODN,NSODN and control groups were 1.67±0.14,2.34±0.17,2.29±0.21.Proliferation of SW1990 cells was significantly decreased in CTGF ASODN transfected group,compared with other two groups(P<0.01).(4)The cells that invaded through the basement membrane filter in CTGF ASODN,NSODN and control groups were 24.88±6.17,52.37±8.62,55.49±8.83,the migration cells were significantly decreased in CTGF ASODN transfected group,compared with other two groups(P<0.01).Conclusions CTGF ASODN could effectively down-regulate the expressions of CTGF,MMP-9,VEGF and inhibit proliferation,invasion of SW1990 cells.
出处 《中华临床医师杂志(电子版)》 CAS 2012年第16期4615-4620,共6页 Chinese Journal of Clinicians(Electronic Edition)
基金 江苏省"333工程"培养资金资助项目(200924) 南通大学自然科学基金(10Z088)
关键词 寡核苷酸类 反义 基质金属蛋白酶9 血管内皮生长因子类 结缔组织生长因子 Oligonucleotides,antisense Matrix metalloproteinase 9 Vascular endothelial growth factors Connective tissue growth factor
  • 相关文献

参考文献2

二级参考文献19

  • 1Yuan-Yu Wang MS,Zai-Yuan Ye MS,Zhong-Sheng Zhao MS,Hou-Quan Tao MD,Yong-Quan Chu MS.High-Level Expression of S100A4 Correlates with Lymph Node Metastasis and Poor Prognosis in Patients with Gastric Cancer[J]. Annals of Surgical Oncology . 2010 (1)
  • 2Nalan Akyürek,Leyla Memi?,?zgür Ekinci,Nurdan K?ktürk,Can ?ztürk.Survivin expression in pre-invasive lesions and non-small cell lung carcinoma[J]. Virchows Archiv . 2006 (2)
  • 3M. A. Christine Pratt,Min-Ying Niu,L. Isabel Renart.Regulation of survivin by retinoic acid and its role in paclitaxel-mediated cytotoxicity in MCF-7 breast cancer cells[J]. Apoptosis . 2006 (4)
  • 4Delvaeye M,De Vriese A,Zwerts F,et al.Role of the2zebrafish survivin genes in vasculo-angiogenesis,neurogenesis,cardiogenesis and hemato-poiesis. BMC Developmental Biology . 2009
  • 5Caldas H,Jaynes FO,Boyer MW,et al.Survivin and Granzyme B-induced apoptosis,a novel anticancer therapy. Molecular Cancer Therapeutics . 2006
  • 6Tsuna M,Kageyama S,Fukuoka J,et al.Significance of S100A4as a prognostic marker of lung squamous cell carcinoma. Anticancer Research . 2009
  • 7Kim JH,Kim CN,Kim SY,et al.Enhanced S100A4protein expression is clinicopathologically significant to metastatic potential and p53dysfunc-tion in colorectal cancer. Oncology Reports . 2009
  • 8Lu CD,Altieri DC,Tanigawa N.Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Research . 1998
  • 9Sarela AI,Macadam RC,Farmery SM,et al.Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut . 2000
  • 10Kami K,Doi R,Koizumi M,et al.Survivin expression is a prognostic marker in pancreatic cancer patients. Journal of Surgery . 2004

共引文献6

同被引文献29

  • 1王威,乔杰,李美芝,马彩虹,刘丽丽,陈咏建.多囊卵巢综合征妇女促排卵后着床窗口期子宫内膜MMP-9和TIMP-1的表达[J].中国生育健康杂志,2005,16(5):271-273. 被引量:1
  • 2Tschan MP,Shan D,Laedrach J. NDRG1/2 expression is inhibited in primary acute myeloid leukemia[J].Leukemia Research,2010.393-398.
  • 3Kim A,Kim MJ,Yang Y. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells[J].Carcinogenesis,2009,(6):927-936.doi:10.1093/carcin/bgp072.
  • 4Yu H,Zhao G,LI H. Candesartan antagonizes pressure overload-evoked cardiac remodeling through Smad7 gene-dependent MMP-9 suppression[J].Gene,2012.301-306.
  • 5Kovacevic Z,Sivagurunathan S,Mangs H. The metastasis suppressor,N-myc downstream regulated gene 1(NDRG1),upregulates p21 via p53-independent mechanisms[J].Carcinogenesis,2011.732-740.
  • 6Gondi CS,Rao JS. Therapeutic potential of siRNA-mediated targeting of urokinase plasminogen activator,its receptor,and matrix metalloproteinases[J].Methods in Molecular Biology,2009.267-281.
  • 7Yang F,Jin C,Jiang YJ. Potential role of soluble VEGFR-1 in antiangiogenesis therapy for cancer[J].Expert Review of Anticancer Therapy,2011.541-549.
  • 8Zhang AH,Rao JN,Zou T. p53-dependent NDRG1 expression induces inhibition of intestinal epithelial cell proliferation but not apoptosis after polyamine depletion[J].American Journal of Physiology-Cell Physiology,2007.C379-C389.
  • 9Said HM,Stein S,Hagemann C. Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo[J].Oncology Reports,2009.237-246.
  • 10于鸿,陈琦,刘晔,赵仲华,郭慕依.转染Smad7基因的大鼠肾小球系膜细胞对Ⅰ、Ⅲ型胶原表达的改变[J].复旦学报(医学版),2008,35(3):436-440. 被引量:6

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部